These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The value of lipavlon in diabetic retinopathy]. François P; Belervacque A; Turut P Bull Soc Ophtalmol Fr; 1970 Apr; 70(4):568-73. PubMed ID: 5474598 [No Abstract] [Full Text] [Related]
3. A double-blind controlled trial of clofibrate in the treatment of diabetic retinopathy. Harrold BP; Marmion VJ; Gough KR Diabetes; 1969 May; 18(5):285-91. PubMed ID: 4894161 [No Abstract] [Full Text] [Related]
4. Clinical, biochemical and pathological studies of long term "clofibrate" therapy. el-Mehairy MM; Attia O; Nabih AE; Nassar I; Ibrahim WN J Trop Med Hyg; 1970 Jul; 73(7):177-81. PubMed ID: 5470220 [No Abstract] [Full Text] [Related]
5. Clofibrate. Truswell AS Br Med J; 1971 Apr; 2(5755):223. PubMed ID: 5575963 [No Abstract] [Full Text] [Related]
6. [Clinical trial of C.P.I.B. (clofibrate) in treatment of diabetic hypertriglyceridemia]. Warembourg H; Jaillard J Lille Med; 1968 Jan; 13(1):Suppl:5-8. PubMed ID: 5745605 [No Abstract] [Full Text] [Related]
7. [Treatment of diabetes insipidus with clofibrate]. Annee Endocrinol; 1971; 23():101-3. PubMed ID: 5562226 [No Abstract] [Full Text] [Related]
8. [The treatment of essential hyperlipidemia with clofibrate]. Reuter W; Seifert A Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:184-7. PubMed ID: 4918619 [No Abstract] [Full Text] [Related]
9. [Present-day management of the general treatment of diabetic retinopathy]. Popa DP; Canciu G Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1978; 27(2):119-21. PubMed ID: 566942 [No Abstract] [Full Text] [Related]
10. [Serum-lipid reducing principles--possibilities for treatment. 6. Indications for the use of clofibrate]. Gustafson A Lakartidningen; 1970 Dec; 67():Suppl IV:75+. PubMed ID: 5511954 [No Abstract] [Full Text] [Related]
11. [Treatment of essential hyperlipemia with clofibrate]. Reuter W; Seifert A Z Gesamte Inn Med; 1969 Jun; 24(12):184-7. PubMed ID: 5404292 [No Abstract] [Full Text] [Related]
12. [Treatment of arteriosclerosis by Atromid]. Ayad H Rev Med Moyen Orient; 1967; 24(6):504-11. PubMed ID: 5264185 [No Abstract] [Full Text] [Related]
13. Serum lipids in an ambulary diabetic clientele. Effect of therapy with Atromidin (clofibrate). Bergqvist N Acta Med Scand; 1970 Mar; 187(3):213-8. PubMed ID: 5444978 [No Abstract] [Full Text] [Related]
17. [Therapeutic trial of a hypolipemiant, 67-96 C, in tinnitus]. Garcin M; Cagnol C Rev Laryngol Otol Rhinol (Bord); 1968; 89(11):708-13. PubMed ID: 5757748 [No Abstract] [Full Text] [Related]
18. Clofibrate and dextrothyroxine in coronary heart diseases. A clinical and biochemical study. Bhatia ML; Setty KR; Roy SB J Assoc Physicians India; 1971 Feb; 19(2):123-9. PubMed ID: 4934418 [No Abstract] [Full Text] [Related]
19. [Clinical study of the effect of ethyl-alpha-p-chlorophenoxybutyrate (clofibrate) in the venous retinal thrombosis]. Cioli S; Nizzola GM Ann Ottalmol Clin Ocul; 1970 Sep; 96(9):477-82. PubMed ID: 5519038 [No Abstract] [Full Text] [Related]
20. [Therapeutic study of clofibrate during pituitrin-sensitive diabetes insipidus in children]. de Gennes JL; Desbois JC; Marie J Ann Pediatr (Paris); 1970 Nov; 17(11):754-9. PubMed ID: 5484620 [No Abstract] [Full Text] [Related] [Next] [New Search]